AAAAAA

   
Results: 1-18 |
Results: 18
CYTOGENETIC FINDINGS IN 303 MEXICAN PATIENTS WITH DE-NOVO ACUTE MYELOBLASTIC-LEUKEMIA
Authors: ARANATREJO RM GOMEZMORALES E RUBIOBORJA ME KASSACKIPINA JU PEREDO AC GUERRERORIVERA S GONZALEZLLAVEN J GUTIERREZROMERO M PIZZUTOCHAVEZ J KOFMANALFARO S
Citation: Rm. Aranatrejo et al., CYTOGENETIC FINDINGS IN 303 MEXICAN PATIENTS WITH DE-NOVO ACUTE MYELOBLASTIC-LEUKEMIA, Archives of medical research, 28(2), 1997, pp. 209-214
BIOAVAILABILITY OF ORAL CYCLOSPORINE IN HEALTHY MEXICAN VOLUNTEERS - EVIDENCE FOR INTERETHNIC VARIABILITY
Authors: PALMAAGUIRRE JA GONZALEZLLAVEN J FLORESMURRIETA FJ CASTANEDAHERNANDEZ G
Citation: Ja. Palmaaguirre et al., BIOAVAILABILITY OF ORAL CYCLOSPORINE IN HEALTHY MEXICAN VOLUNTEERS - EVIDENCE FOR INTERETHNIC VARIABILITY, Journal of clinical pharmacology, 37(7), 1997, pp. 630-634
INTERFERON IN THE SUPPRESSION OF PHILADEL PHIA-CHROMOSOME OF CHRONIC MYELOID-LEUKEMIA
Authors: ARANATREJO RM OVILLAMARTINEZ R GOMEZMORALES E MEILLONGARCIA L CERVANTESPEREDO A GONZALEZLLAVEN J PIZZUTOCHAVEZ J KOFMANALFARO S
Citation: Rm. Aranatrejo et al., INTERFERON IN THE SUPPRESSION OF PHILADEL PHIA-CHROMOSOME OF CHRONIC MYELOID-LEUKEMIA, Revista de Investigacion Clinica, 49(3), 1997, pp. 209-214
ACUTE-LEUKEMIA
Authors: SANCHEZCORTES E GONZALEZLLAVEN J
Citation: E. Sanchezcortes et J. Gonzalezllaven, ACUTE-LEUKEMIA, Revista de Investigacion Clinica, 49, 1997, pp. 103-107
INCREASED CONCENTRATION OF TISSUE-PLASMINOGEN ACTIVATOR PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 COMPLEX (TPA-PAI-1) AND UROKINASE PLASMINOGEN-ACTIVATOR (UPA) IN CYTOSOLS OF EARLY-STAGE OF MALIGNANT BREAST-CANCER
Authors: GARCIAMANZANO A GONZALEZLLAVEN J RICOGONZALEZ T BASELISCASTANON JC GARCIACEBADA M BAHENARESENDIZ P DELEON LD
Citation: A. Garciamanzano et al., INCREASED CONCENTRATION OF TISSUE-PLASMINOGEN ACTIVATOR PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 COMPLEX (TPA-PAI-1) AND UROKINASE PLASMINOGEN-ACTIVATOR (UPA) IN CYTOSOLS OF EARLY-STAGE OF MALIGNANT BREAST-CANCER, Blood, 90(10), 1997, pp. 3131-3131
THE BCR-ABL FUSION TRANSCRIPT TYPE IS DIFFERENT IN ONE MEXICAN POPULATION
Authors: ROSAS A AYALA M GONZALEZLLAVEN J RODRIGUEZ R MIRANDA E GARIGLIO P
Citation: A. Rosas et al., THE BCR-ABL FUSION TRANSCRIPT TYPE IS DIFFERENT IN ONE MEXICAN POPULATION, Blood, 90(10), 1997, pp. 4013-4013
2ND BONE-MARROW TRANSPLANT (2BMT) AND DONOR LEUKOCYTE INFUSIONS (DLI)TO TREAT RELAPSE OR GRAFT FAILURE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
Authors: VELAOJEDA J TRIPPVILLANUEVA F SANCHEZCORTES E AYALASANCHEZ M GONZALEZLLAVEN J
Citation: J. Velaojeda et al., 2ND BONE-MARROW TRANSPLANT (2BMT) AND DONOR LEUKOCYTE INFUSIONS (DLI)TO TREAT RELAPSE OR GRAFT FAILURE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 90(10), 1997, pp. 4479-4479
TOPICAL ORAL GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) FOR THE TREATMENT OF MUCOSITIS AFTER BONE-MARROW TRANSPLANTATION
Authors: VELAOJEDA J TRIPPVILLANUEVA F SANCHEZCORTES E GONZALEZLLAVEN J
Citation: J. Velaojeda et al., TOPICAL ORAL GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) FOR THE TREATMENT OF MUCOSITIS AFTER BONE-MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 3739-3739
ANXIETY AND DEPRESSION DURING BONE-MARROW TRANSPLANTATION (BMT)
Authors: ILLESCAS RR AMAYA AA CABALLERO M GONZALEZLLAVEN J VELAOJEDA J TRIPP F
Citation: Rr. Illescas et al., ANXIETY AND DEPRESSION DURING BONE-MARROW TRANSPLANTATION (BMT), Blood, 88(10), 1996, pp. 3801-3801
PHARMACOKINETIC PARAMETERS OF 2 DIFFERENT FORMULATIONS OF CYCLOSPORINE-A ADMINISTERED AFTER FAT RICH DIET
Authors: GONZALEZLLAVEN J PALMAAGUIRRE JA GARCIAARREOLA R BRIZUELA V MORANLIRA S VELAOJEDA J CASTANEDAHDZ JG
Citation: J. Gonzalezllaven et al., PHARMACOKINETIC PARAMETERS OF 2 DIFFERENT FORMULATIONS OF CYCLOSPORINE-A ADMINISTERED AFTER FAT RICH DIET, Blood, 86(10), 1995, pp. 1571-1571
REGIONAL INTRARTERIAL CHEMOTHERAPY (CT) FOR SINONASAL ANGIOCENTRIC REFRACTORY LYMPHOMA
Authors: TRIPPVILLANUEVA F GOMEZ L DIAZLEON L ZARZOSAMORALES M GONZALEZLLAVEN J BAHENA P
Citation: F. Trippvillanueva et al., REGIONAL INTRARTERIAL CHEMOTHERAPY (CT) FOR SINONASAL ANGIOCENTRIC REFRACTORY LYMPHOMA, Blood, 86(10), 1995, pp. 3285-3285
PENTOXIFYLLINE (PTX) IN THE PREVENTION OF HEPATIC VENO-OCLUSIVE DISEASE (VOD) AFTER BONE-MARROW TRANSPLANTATION (BMT)
Authors: VELAOJEDA J TRIPPVILLANUEVA F SANCHEZCORTES E ZARZOSA ME GARCIAMANZANO A GONZALEZLLAVEN J
Citation: J. Velaojeda et al., PENTOXIFYLLINE (PTX) IN THE PREVENTION OF HEPATIC VENO-OCLUSIVE DISEASE (VOD) AFTER BONE-MARROW TRANSPLANTATION (BMT), Blood, 86(10), 1995, pp. 3872-3872
RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF)AND LOW-DOSE RECOMBINANT-HUMAN-ERYTHROPOIETIN (EPO) IN BONE-MARROW TRANSPLANTATION (BMT)
Authors: VELAOJEDA J TRIPPVILLANUEVA F SANCHEZCORTES E ZARZOSA ME GONZALEZLLAVEN J
Citation: J. Velaojeda et al., RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF)AND LOW-DOSE RECOMBINANT-HUMAN-ERYTHROPOIETIN (EPO) IN BONE-MARROW TRANSPLANTATION (BMT), Blood, 86(10), 1995, pp. 3873-3873
LONG-TERM FOLLOW-UP OF 24 PATIENTS (PT) WITH ACUTE PROMYELOCYTIC LEUKEMIA (APL) TREATED WITH ATRA AND CONSOLIDATION CHEMOTHERAPY (QT)
Authors: GONZALEZLLAVEN J SANCHEZCORTEZ E VELAOJEDA J TRIPPVILLANUEVA F
Citation: J. Gonzalezllaven et al., LONG-TERM FOLLOW-UP OF 24 PATIENTS (PT) WITH ACUTE PROMYELOCYTIC LEUKEMIA (APL) TREATED WITH ATRA AND CONSOLIDATION CHEMOTHERAPY (QT), Blood, 84(10), 1994, pp. 10000619-10000619
CHEMOTHERAPY AND INTERFERON ALFA-2B IN NEWLY-DIAGNOSED PATIENTS WITH MULTIPLE-MYELOMA
Authors: VELAOJEDA J GARCIARUIZESPARZA MA VAZQUEZ V SANCHEZCORTES E TRIPPVILLANUEVA F GONZALEZLLAVEN J
Citation: J. Velaojeda et al., CHEMOTHERAPY AND INTERFERON ALFA-2B IN NEWLY-DIAGNOSED PATIENTS WITH MULTIPLE-MYELOMA, Blood, 84(10), 1994, pp. 10000659-10000659
MULTIPLE-MYELOMA METABOLIC STUDY
Authors: VELAOJEDA J ESPARZA MAGR ALFAROCANO L RABAGOCORNEJO T PADILLAGONZALEZ I GONZALEZLLAVEN J
Citation: J. Velaojeda et al., MULTIPLE-MYELOMA METABOLIC STUDY, Blood, 84(10), 1994, pp. 10000660-10000660
ALL-TRANS-RETINOIC ACID (ATRA) FOR ACUTE PROMYELOCYTIC LEUKEMIA (APL)- REPORT FROM THE MEXICAN GROUP
Authors: RUBIOBORJA ME LABARDINI MJ ZARATE P GOMEZALMAGUER D VELAZQUEZ F GONZALEZLLAVEN J OVILLA MR SANCHEZ CE BORBOLLA R
Citation: Me. Rubioborja et al., ALL-TRANS-RETINOIC ACID (ATRA) FOR ACUTE PROMYELOCYTIC LEUKEMIA (APL)- REPORT FROM THE MEXICAN GROUP, Blood, 82(10), 1993, pp. 10000546-10000546
PERSISTENT ACTIVITY OF UROKINASE-TYPE OF PLASMINOGEN-ACTIVATOR (UPA) IN ACUTE PROMYELOCYTIC LEUKEMIA ON REMISSION
Authors: GONZALEZLLAVEN J GARCIAMANZANO A",OCADIZDELGADO,"SANCHEZCORTES E
Citation: J. Gonzalezllaven et E. Garciamanzano A",ocadizdelgado,"sanchezcortes, PERSISTENT ACTIVITY OF UROKINASE-TYPE OF PLASMINOGEN-ACTIVATOR (UPA) IN ACUTE PROMYELOCYTIC LEUKEMIA ON REMISSION, Blood, 82(10), 1993, pp. 10000593-10000593
Risultati: 1-18 |